Literature DB >> 8878423

Triiodothyronine induces over-expression of alpha-smooth muscle actin, restricts myofibrillar expansion and is permissive for the action of basic fibroblast growth factor and insulin-like growth factor I in adult rat cardiomyocytes.

M A Gosteli-Peter1, B A Harder, H M Eppenberger, J Zapf, M C Schaub.   

Abstract

Effects of triiodothyronine (T3) on the expression of cytoskeletal and myofibrillar proteins in adult rat cardiomyocytes (ARC) were followed during two weeks of culture in the presence of 20% T3-depleted (stripped) FCS. Control cultures expressed mainly beta-myosin heavy chain (MHC) mRNA. T3 caused a switch to alpha-MHC expression and a dose-dependent increase of alpha-smooth muscle (alpha-sm) actin mRNA and protein. In parallel, the number of alpha-sm actin immunoreactive cells increased from 1% in controls to 29 and 62% in ARC treated with 5 and 100 nM T3. In the presence of T3, cells exhibited a higher beating rate than controls. The distribution of myofibrils in T3-treated cells was restricted to the perinuclear area with a sharp boundary. Only 5% of the control cells but 30 and 62% of the T3-treated (5 and 100 nM) ARC showed this restricted myofibrillar phenotype. Basic fibroblast growth factor (bFGF) which restricts myofibrillar growth and upregulates alpha-sm actin in ARC cultured with normal FCS had no effect on alpha-sm actin in ARC cultured in stripped FCS, but potentiated the effect of T3. In contrast, insulin-like growth factor I (IGF I), which suppresses alpha-sm actin and stimulates myofibrillogenesis in the presence of normal FCS suppressed T3-induced alpha-sm actin expression in stripped FCS. Thus, T3 appears to be permissive for the action of bFGF and IGF I on alpha-sm actin expression.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8878423      PMCID: PMC507611          DOI: 10.1172/JCI118972

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  42 in total

Review 1.  Thyroid hormone regulation of gene expression.

Authors:  G A Brent; D D Moore; P R Larsen
Journal:  Annu Rev Physiol       Date:  1991       Impact factor: 19.318

Review 2.  Cardiac myocytes as targets for the action of peptide growth factors.

Authors:  M D Schneider; T G Parker
Journal:  Circulation       Date:  1990-05       Impact factor: 29.690

3.  Reexpression of alpha-smooth muscle actin isoform in cultured adult rat cardiomyocytes.

Authors:  M Eppenberger-Eberhardt; I Flamme; V Kurer; H M Eppenberger
Journal:  Dev Biol       Date:  1990-06       Impact factor: 3.582

4.  Acidic fibroblast growth factor mRNA is expressed by cardiac myocytes in culture and the protein is localized to the extracellular matrix.

Authors:  H L Weiner; J L Swain
Journal:  Proc Natl Acad Sci U S A       Date:  1989-04       Impact factor: 11.205

5.  Peptide growth factors can provoke "fetal" contractile protein gene expression in rat cardiac myocytes.

Authors:  T G Parker; S E Packer; M D Schneider
Journal:  J Clin Invest       Date:  1990-02       Impact factor: 14.808

6.  Longevity of adult ventricular rat heart muscle cells in serum-free primary culture.

Authors:  A Volz; H M Piper; B Siegmund; P Schwartz
Journal:  J Mol Cell Cardiol       Date:  1991-02       Impact factor: 5.000

7.  Thyroid hormones transcriptionally regulate the beta 1-adrenergic receptor gene in cultured ventricular myocytes.

Authors:  S W Bahouth
Journal:  J Biol Chem       Date:  1991-08-25       Impact factor: 5.157

8.  Decreased adrenergic sensitivity in patients with hypothyroidism.

Authors:  R Polikar; B Kennedy; A Maisel; M Ziegler; J Smith; H Dittrich; P Nicod
Journal:  J Am Coll Cardiol       Date:  1990-01       Impact factor: 24.094

Review 9.  Effects of growth factors on myogenic differentiation.

Authors:  J R Florini; K A Magri
Journal:  Am J Physiol       Date:  1989-04

10.  The vascular smooth muscle alpha-actin gene is reactivated during cardiac hypertrophy provoked by load.

Authors:  F M Black; S E Packer; T G Parker; L H Michael; R Roberts; R J Schwartz; M D Schneider
Journal:  J Clin Invest       Date:  1991-11       Impact factor: 14.808

View more
  7 in total

1.  Thyroid hormone changes cardiomyocyte shape and geometry via ERK signaling pathway: potential therapeutic implications in reversing cardiac remodeling?

Authors:  C Pantos; Christodoulos Xinaris; Iordanis Mourouzis; Vassiliki Malliopoulou; Elissavet Kardami; Dennis V Cokkinos
Journal:  Mol Cell Biochem       Date:  2006-10-06       Impact factor: 3.396

Review 2.  N-Cadherin: structure, function and importance in the formation of new intercalated disc-like cell contacts in cardiomyocytes.

Authors:  C Zuppinger; M Eppenberger-Eberhardt; H M Eppenberger
Journal:  Heart Fail Rev       Date:  2000-10       Impact factor: 4.214

Review 3.  Remodeling and dedifferentiation of adult cardiomyocytes during disease and regeneration.

Authors:  Marten Szibor; Jochen Pöling; Henning Warnecke; Thomas Kubin; Thomas Braun
Journal:  Cell Mol Life Sci       Date:  2013-12-10       Impact factor: 9.261

4.  A brief history of M. C. Schaub's legacies: a life dedicated to heart and muscle research : In memoriam Marcus C. Schaub (1936-2018).

Authors:  Michael Zaugg; Eliana Lucchinetti
Journal:  J Muscle Res Cell Motil       Date:  2018-08       Impact factor: 2.698

5.  Hypothyroidism and its rapid correction alter cardiac remodeling.

Authors:  Georges Hajje; Youakim Saliba; Tarek Itani; Majed Moubarak; Georges Aftimos; Nassim Farès
Journal:  PLoS One       Date:  2014-10-15       Impact factor: 3.240

6.  Repression of Osmr and Fgfr1 by miR-1/133a prevents cardiomyocyte dedifferentiation and cell cycle entry in the adult heart.

Authors:  Melissa Valussi; Johannes Besser; Katharina Wystub-Lis; Sven Zukunft; Manfred Richter; Thomas Kubin; Thomas Boettger; Thomas Braun
Journal:  Sci Adv       Date:  2021-10-13       Impact factor: 14.136

Review 7.  The Role of Oncostatin M and Its Receptor Complexes in Cardiomyocyte Protection, Regeneration, and Failure.

Authors:  Thomas Kubin; Praveen Gajawada; Peter Bramlage; Stefan Hein; Benedikt Berge; Ayse Cetinkaya; Heiko Burger; Markus Schönburg; Wolfgang Schaper; Yeong-Hoon Choi; Manfred Richter
Journal:  Int J Mol Sci       Date:  2022-02-05       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.